MOON101 / Moonlight Therap - LARVOL DELTA

Moonlight Therapeutics Completes Pre-IND Meeting With the FDA for MOON101 for Peanut Allergy (Moonlight Press Release) - "Moonlight Therapeutics...announced today it successfully completed a pre-Investigational New Drug Application (pre-IND) meeting with the U.S. Food and Drug Administration (FDA) to discuss the regulatory pathway for the development of MOON101 for the treatment of peanut allergy. More specifically, Moonlight has received guidance from the FDA on a first-in-human clinical trial for MOON101 in peanut allergic children and adults....Moonlight expects to submit the IND package for MOON101 to the FDA later this year."

FDA event • IND • Food Hypersensitivity